Insider Trading activities at Novo Integrated Sciences, Inc. (TTEG)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Novo Integrated Sciences, Inc. (TTEG) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Novo Integrated Sciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1138978.

Total stock buying since 2021: $91,095.
Total stock sales since 2021: $0.
Total stock option exercises since 2021: $0.


1 insider reported insider trading activities at Novo Integrated Sciences, Inc. (TTEG):
Insider trading activities of Oliva Robert Letterio

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Novo Integrated Sciences, Inc. (TTEG).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2022 10,000 $22,325 0 $0 0 $0
2021 22,555 $68,770 0 $0 0 $0

Table 2. Monthly summary of insider trading at Novo Integrated Sciences, Inc. (TTEG).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2022-04 10,000 $22,325 0 $0 0 $0
2021-04 13,000 $27,560 0 $0 0 $0
2021-02 9,555 $41,210 0 $0 0 $0

Table 3. Detailed insider trading at Novo Integrated Sciences, Inc. (TTEG)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2022-04-20 Oliva Robert Letterio Buy 5,000 2.24 11,200
2022-04-19 Oliva Robert Letterio Buy 5,000 2.23 11,125
2021-04-21 Oliva Robert Letterio Buy 13,000 2.12 27,560
2021-02-23 Oliva Robert Letterio Buy 200 4.45 890
2021-02-22 Oliva Robert Letterio Buy 9,355 4.31 40,320

Insider trading activities including stock purchases, stock sales, and option exercises of TTEG listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Novo Integrated Sciences, Inc. (symbol TTEG, CIK number 1138978) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.